Layered bionanocomposites as carrier for procainamideKEVADIYA, Bhavesh D; JOSHI, Ghanshyam V; BAJAJ, Hari C et al.International journal of pharmaceutics (Print). 2010, Vol 388, Num 1-2, pp 280-286, issn 0378-5173, 7 p.Article

FLUOROMETRIC ASSAY FOR N-ACETYLPROCAINAMIDE.MATUSIK E; GIBSON TP.1975; CLIN. CHEM.; U.S.A.; DA. 1975; VOL. 21; NO 13; PP. 1899-1902; BIBL. 15 REF.Article

Reversed-phase liquid chromatography method for measurement of procainamide and three metabolites in serum and urine: percent of dose excreted as deethyl metabolitesCOYLE, J. D; MACKICHAN, J. J; BOUDOULAS, H et al.Journal of pharmaceutical sciences. 1987, Vol 76, Num 5, pp 402-405, issn 0022-3549Article

Pharmacokinetic and pharmacodynamic analysis of platinum after combined treatment of cisplatin and procainamide hydrochloride in mice bearing P388 leukemiaVANNOZZI, Maria O; OTTONE, Massimo; MARIGGIO, Maria A et al.Anticancer research. 2003, Vol 23, Num 2B, pp 1509-1516, issn 0250-7005, 8 p.Article

Proceedings/Procainamide, international symposium: 29th annual meeting, International college of angiology, Montreux, CHE, July 25, 1987Angiology. 1988, Vol 39, Num 7, pp 639-699, issn 0003-3197, 2Conference Proceedings

Ranitidine and procainamide absorptionSOMOGYI, A; BOCHNER, F.British journal of clinical pharmacology. 1985, Vol 20, Num 2, pp 182-183, issn 0306-5251Article

REMISSION OF PROCAINAMIDE-INDUCED LUPUS ERYTHEMATOSUS WITH N-ACETYLPROCAINAMIDE THERAPYSTEC GP; LERTORA JJL; ATKINSON AJ JR et al.1979; ANN. INTERN. MED.; USA; DA. 1979; VOL. 90; NO 5; PP. 799-801; BIBL. 9 REF.Article

Pharmacokinetic and pharmacodynamic interaction of N-acetyl procainamide and procainamide in humansFUNCK-BRENTANO, C; LIGHT, R. T; LINEBERRY, M. D et al.Journal of cardiovascular pharmacology. 1989, Vol 14, Num 3, pp 364-373, issn 0160-2446Article

EFFECTS OF N-ACETYLPROCAINAMIDE AS COMPARED WITH PROCAINAMIDE IN ISOLATED RAT ATRIA. = EFFETS DU N-ACETYLPROCAINAMIDE PAR COMPARAISON AVEC LE PROCAINAMIDE DANS L'OREILLETTE ISOLEE DU RATREFSUM H; FRISLID K; LUNDE PKM et al.1975; EUROP. J. PHARMACOL.; NETHERL.; DA. 1975; VOL. 33; NO 1; PP. 47-52; BIBL. 25 REF.Article

Reactivation of tumor suppressor genes by the cardiovascular drugs Hydralazine and procainamide ad their potential use in cancer therapySEGURA-PACHECO, Blanca; TREJO-BECERRIL, Catalina; PEREZ-CARDENAS, Enrique et al.Clinical cancer research. 2003, Vol 9, Num 5, pp 1596-1603, issn 1078-0432, 8 p.Article

THE QUANTITATIVE DISPOSITION OF PROCAINAMIDE AND N-ACETYLPROCAINAMIDE IN THE RAT.SCHNECK DW; GROVE K; DEWITT FO et al.1978; J. PHARMACOL. EXPER. THERAPEUT.; U.S.A.; DA. 1978; VOL. 204; NO 1; PP. 219-225; BIBL. 20 REF.Article

Class I antiarrhythmic agents: quinidine, procainamide and N-acetylprocainamide, disopyramideRODEN, D. M; WOOSLEY, R. L.Pharmacology & therapeutics (Oxford). 1983, Vol 23, Num 2, pp 179-191, issn 0163-7258Article

EFFICACY AND SAFETY OF N-ACETYLPROCAINAMIDE IN LONG-TERM TREATMENT OF VENTRICULAR ARRHYTHMIASATKINSON AJ JR; LERTORA JJL; KUSHNER W et al.1983; CLINICAL PHARMACOLOGY AND THERAPEUTICS; ISSN 0009-9236; USA; DA. 1983; VOL. 33; NO 5; PP. 565-576; BIBL. 24 REF.Article

HEMODYNAMIC EFFECTS OF N-ACETYLPROCAINAMIDE COMPARED WITH PROCAINAMIDE IN CONSCIOUS DOGSBADKE FR; WALSH RA; CRAWFORD MH et al.1981; CIRCULATION; ISSN 0009-7322; USA; DA. 1981; VOL. 64; NO 6; PP. 1142-1150; BIBL. 25 REF.Article

N-acetylprocainamide is a less potent inducer of T cell autoreactivity than procainamideRICHARDSON, B; CORNACCHIA, E; GOLBUS, J et al.Arthritis and rheumatism. 1988, Vol 31, Num 8, pp 995-999, issn 0004-3591Article

Metabolism of procainamide to the cytotoxic hydroxylamine by neutrophils activated in vitroRUBIN, R. L; CURNUTTE, J. T.The Journal of clinical investigation. 1989, Vol 83, Num 4, pp 1336-1343, issn 0021-9738, 8 p.Article

Intense pseudotransport of a cationic drug mediated by vacuolar ATPase : Procainamide-induced autophagic cell vacuolizationMORISSETTE, Guillaume; LODGE, Robert; MARCEAU, Francois et al.Toxicology and applied pharmacology. 2008, Vol 228, Num 3, pp 364-377, issn 0041-008X, 14 p.Article

Effect of 5-azacytidine and procainamide on CD3-ζ chain expression in jurkat T cellsJANUCHOWSKI, Radosław; JAGODZINSKI, Pawel P.Biomedicine & pharmacotherapy. 2005, Vol 59, Num 3, pp 122-126, issn 0753-3322, 5 p.Article

Myopathy after short term administration of procainamideLEWIS, C. A; BOHEIMER, N; ROSE, P et al.British medical journal (1857). 1986, Vol 292, Num 6520, pp 593-594, issn 0007-1447Article

Electroanalytical studies of beta-adrenergic blocking agents; N-isopropylethanolamine derivatives; procainamideBISHOP, E; HUSSEIN, W.Analyst (London. 1877. Print). 1984, Vol 109, Num 1, pp 65-71, issn 0003-2654Article

INTERFERENCE BY TRACES OF ACETIC ANHYDRIDE IN NONAQUEOUS TITRIMETRY OF PRIMARY AROMATIC AMINES: IMPROVED TITRATIONS FOR PROCAINAMIDE HYDROCHLORIDE = INTERFERENCE DES TRACES D'ANHYDRIDE ACETIQUE DANS LE TITRAGE NON AQUEUX DES AMINES PRIMAIRES AROMATIQUES: TITRATIONS AMELIOREES POUR LE CHLORHYDRATE DE PROCAINAMIDEKADIN H.1974; J. PHARM. SCI.; U.S.A.; DA. 1974; VOL. 63; NO 6; PP. 919-923; BIBL. 9REF.Article

DNA methylation and autoimmune diseaseRICHARDSON, Bruce.Clinical immunology (Orlando, Fla. Print). 2003, Vol 109, Num 1, pp 72-79, issn 1521-6616, 8 p.Article

Effect of procainamide on the induction of ventricular fibrillation by sequential ventricular stimulationMARAKAWA, Y; SUGIMOTO, T.Japanese Circulation Journal. 1987, Vol 51, Num 2, pp 203-207, issn 0047-1828Article

Population pharmacokinetics of procainamide from routine clinical dataGRASELA, T. H; SHEINER, L. B.Clinical pharmacokinetics. 1984, Vol 9, Num 6, pp 545-554, issn 0312-5963Article

SPECTROPHOTOFLUOROMETRIC ANALYSIS OF PROCAINAMIDE AND SULFADIAZINE IN PRESENCE OF PRIMARY ALIPHATIC AMINES BASED ON REACTION WITH FLUORESCAMINE = ANALYSE SPECTROPHOTOFLUOROMETRIQUE DE LA PROCAINAMIDE ET DE LA SULFADIAZINE EN PRESENCE D'AMINES ALIPHATIQUES PRIMAIRES BASEE SUR LA REACTION AVEC LA FLUORESCAMINESTERLING JM; HANEY WG.1974; J. PHARM. SCI.; U.S.A.; DA. 1974; VOL. 63; NO 9; PP. 1448-1450; BIBL. 10REF.Article